Introduction
============

Dementia with Lewy bodies (DLB) is characterized by dementia, relatively mild parkinsonism, visual hallucinations, and fluctuations in conscious level. Unlike Alzheimer\'s disease (AD), DLB shows cortical-subcortical degeneration (Horoupian and Wasserstein, [@B19]), which can affect both initiation and execution of eye movements. The abnormal cytoplasmic inclusions that develop in DLB are very similar to those observed in Pakinson\'s disease (PD). Symptoms and pathophysiology of DLB overlaps also with that of AD. Mosimann et al. ([@B32]) used gap and overlap saccade tasks in DLB, AD, PD, and age-matched controls; in the former task the fixation point extinguishes 200 ms before target onset while in the latter fixation point stays on during the target presentation. The gap task usually elicits shorter latency saccades, some of them being extra short (80--120 ms); they are called express saccades. Mosimann et al. ([@B32]) reported long latency in DLB patients even in the gap task. In contrast, AD and PD patients made normal short latency saccades in the same task. For more voluntary saccades, e.g., predictive saccades, antisaccades, all groups of patients (DLB, AD, and PD) showed abnormally long latencies. Mosimann et al. ([@B32]) emphasized the need for further research on eye movements as such studies may have a potential for differential diagnosis for these diseases. The study is a part of a long term program aiming to provide a complete characterization of saccades in DLB, AD patients and controls (national PHRC). As a first step, here we report a study of saccades in the gap and overlap tasks in a group of DLB patients and age-matched controls. It examines saccades for both horizontal and vertical directions, and the occurrence of express saccades in the gap task versus overlap in healthy and DLB patients. In our laboratory normal rates of express saccades, about 20%, were observed for both young and elderly subjects (Yang and Kapoula, [@B55]; Yang et al., [@B55]). For PD patients, however, the results of express saccades are controversial. Armstrong et al. ([@B2]) and van Stockum et al. ([@B52]) reported more express in PD patients than in healthy subjects while other studies reported less express (Ratmanov et al., [@B38]) or no difference (Roll et al., [@B42]). Different cortical-subcortical areas, such as, superior colliculus (Isa and Kobayashi, [@B22]), posterior parietal cortex (Kapoula et al., [@B24], [@B25]), or frontal eye field (Kurkin et al., [@B27]) could be involved in the generation saccades. Triggering of express type of saccades is believed to involve a shorter circuit, e.g., retino-superior colliculus, or retino-occipital-parietal-superior colliculus, while triggering of voluntary saccades involves a more extended circuit including the frontal lobe (Pierrot-Deseilligny et al., [@B36], [@B35]).

The second goal of this study is to examine accuracy and speed characteristics of saccades. Saccade velocity depends mainly on function of brainstem structures (Paramedian Pontine reticular Formation -- PPRF for horizontal saccades, the rostral interstitial nucleus of medial longitudinal fasciculus -- riMLF for vertical); accuracy of saccades depends on both cortical and subcortical areas (Leigh and Zee, [@B28]). The metrics and dynamics of saccadic eye movements have not yet been studied in patients with DLB. In the literature, the effect of normal aging on the accuracy of saccades is controversial. For horizontal saccades in healthy elderly, some studies (Sharpe and Zackon, [@B46]; Tedeschi et al., [@B49]) reported a significant increase in the percentage of hypometric amplitude, especially for targets eccentricities larger than 20º (Irving et al., [@B21]). However, many other studies (Warabi et al., [@B53]; Moschner and Baloh, [@B31]; Munoz et al., [@B33]) found no effect of aging on saccade metrics. A similar controversy exists for vertical saccades (Huaman and Sharpe, [@B20]; Yang and Kapoula, [@B56]). On the other hand, abnormality in accuracy of saccades has been found in patients with dementia, such as AD, frontotemporal dementia and semantic dementia (Shafiq-Antonacci et al., [@B45]; Garbutt et al., [@B14]).

Concerning the speed of saccades many studies described reduction in peak velocity in normal elderly relative to young subjects (Sharpe and Zackon, [@B46]; Tedeschi et al., [@B49]) and in patients with AD relative to healthy elderly (Shafiq-Antonacci et al., [@B45]). Yet, these reductions in peak velocity were most evident with large amplitude saccades, usually to targets beyond 20° eccentricity. Note that in another study (Munoz et al., [@B33]), no aging effects were observed either on accuracy or on peak velocity (for target at 20º of eccentricity). Thus whether saccade accuracy and speed are subject to aging is controversial. But there is evidence for their abnormalities in dementia. As DLB patients are reported to have both cortical and subcortical deficits we expect to find abnormalities in all parameters of saccades (latency, accuracy and speed).

Finally, patients with DLB are known to have cognitive performance with high fluctuation of attention. We wondered to what extent clinically assessed fluctuation is associated with variability in saccade parameters. A few previous studies (Munoz et al., [@B33]; Yang et al., [@B54]) found that variability of latency was significantly larger in children than in adults. More recently, the former group also reported high variability of saccade latency in elderly (Peltsch et al., [@B34]). High variability of saccade latency in studies with patients can point particular neural deficits. For instance, Blekher et al. ([@B4]) showed that patients with Huntington\'s disease demonstrated increased error rate, increased mean latency and increased variability of latency for memory-guided saccades and antisaccades. Thus, the present study including variability of all parameters allows complete characterization of saccade performance in DLB patients.

Materials and Methods
=====================

Subjects
--------

Ten healthy subjects aged between 65 and 88 years (mean 78.5 ± 6.8) were recruited either among senior laboratory workers, or in the ophthalmology service in the hospital, coming for routine examination and spectacle correction. They had corrected visual acuity above 5/10. The cognitive performance as measured by Mini Mental State Examination (Folstein et al., [@B13]) was more than 28 of 30 points. No subject showed visual, neurological, psychiatric disorders or received medication with neural system effects. Binocular vision was assessed with TNO test for stereoscopic vision (Test designed by the Netherlands Organization for Applied Scientific Research -- TNO); all individual scores were normal, 60′ of arc or better.

Nineteen patients were recruited from the geriatric service in the hospital Pitié Salpêtrière (Paris). Recruitment was done using the consensus guidelines to diagnose DLB. All DLB patients had progressive cognitive decline of sufficient magnitude to interfere with normal social or occupational function and at least two following signs: fluctuating cognition with pronounced variation in attention and alertness, visual hallucinations and spontaneous features of parkinsonism. Moreover, DLB patients were different from Alzheimer patients by their neuropsychological characteristics (sub cortico-frontal memory profile, visuo-spatial deficits, executive syndrome). They were different from Parkinson\'s disease because cognitive decline appeared before or at the same time as parkinsonism. Subjects with other cerebral pathology (e.g., stroke or significant white matter changes) were excluded by cerebral CT or MRI. All subjects with known history of macular degeneration or coexisting medical illness that could interfere with cognitive or visual testing were excluded. For 4 of 19 subjects no eye movement recording was possible because of recording difficulty or refusing the task. Ten patients with DLB completed all the oculomotor tests. Their ages were from 73 to 89 years (mean 81.6 ± 4.7 years). MMSE, Instrumental activities of daily living (Israêl, [@B23]), Dementia Rating Scale (Mattis, [@B29]), Hoehn and Yahr ([@B18]) Scale were used to assess functional, neuropsychiatric symptoms and fluctuation. Demographical and clinical characteristics of these groups were shown in Table [1](#T1){ref-type="table"}. Eight subjects were under medication "Exelon" (Simard and van Reekum, [@B47]).

###### 

**Demographical and clinical characteristics of the groups**.

                                        Control      DLB
  ------------------------------------- ------------ ------------
  *n*                                   10           10
  Age (years)                           78.2 ± 4.6   81.6 ± 4.7
  Education (years)                     13 ± 2.1     12.1 ± 3.4
  Estimated dementia duration (years)   NA           5.1 ± 2.5
  MMSE (max. 30)                        28.7 ± 0.8   22 ± 4.6
  Mattis                                             114 ± 12
  IADL                                               2.7 ± 1.0
  Hoehn and Yahr scale                               1.6 ± 1.0
  Fluctuation                           NA           (+/+++)

*MMSE -- Mini mental state examination (max. = normal); Mattis -- Mattise dementia rating scale (max. 144 = normal); IADL -- Instrumental activities of daily living (max. 4 = normal); Hoehn and Yahr scale -- symptoms of Parkinson\'s disease progress (max. 5, 0 = normal)*.

The investigation adhered to the tenets of the Declaration of Helsinki and was approved by the institutional human experimentation committee (CPP Pitié Salpêtrière). Informed consent was obtained from all subjects after the nature of the procedure had been explained.

Visual display
--------------

The visual display, shown in Figure [1](#F1){ref-type="fig"}A, was composed by five white luminous dots (angular size 0.2°), presented on a black computer screen. One of these five dots was at the center of the screen, two were at an eccentricity of ±10° horizontally and two were at an eccentricity of ±10° vertically.

![**Experimental design**. **(A)** Spatial arrangement. Five white luminous dots (angular size 0.2°) were presented on a black computer screen at 57 cm from the subject (required convergence 6°), one at the center of the screen; the others at an eccentricity of ±10° horizontally or vertically. **(B,C)** Temporal arrangement. Each trial started by lighting one central dot during approximately 1500--2000 ms. For the gap task, between the fixation offset and the target onset, there was a gap of 200 ms **(B)**; for the overlap task, the fixation stays on 200 ms after the target onset **(C)**. The target, one of the eccentric dots, appears for 1500 ms.](fneur-01-00138-g001){#F1}

The subject was comfortably seated in an adapted chair, his head resting on a chin and frontal support. The subject viewed binocularly; all dots were highly visible.

Fixation and oculomotor tasks: gap and overlap tasks
----------------------------------------------------

Each trial started by lighting a fixation dot at the center. The fixation dot stayed on for a random period between 1.5 and 2 s. In the gap task, there was a time interval of 200 ms between the offset of the fixation point and the onset of the saccade target. The target dot was kept on for 1.5 s (Figure [1](#F1){ref-type="fig"}B). In the overlap task, the fixation point remained illuminated for 200 ms after the target dot appeared. The target stayed on also for another 1.5 s (Figure [1](#F1){ref-type="fig"}C). Subjects were required to make a saccade to the target point as rapidly and accurately as possible. A period of complete darkness of 500 ms was for break. Subjects were instructed to use this period for blinks. The total mean length of each trial was about 4 s. In each block only gap or overlap task was used randomly for four directions, targets at 10°, left or right, up or down (10 trails for each direction, total 40 trials). One block for each task lasted 4--5 min. Total duration of the recording was about 10 min.

A calibration sequence was performed at the beginning; the target made the following predictive sequence for each viewing distance: center, 10° to left, center, 10° to right, center, 10° to up, center, 10° to down, center; the target stayed at each location for 2 s. From these recordings we extracted calibration factors.

Eye movement recording
----------------------

Horizontal and vertical eye movements were recorded binocularly with the EyeLink II device. Each channel was sampled at 250 Hz. The system has a spatial resolution of 0.025° in pupil-CR mode and saccade event resolution of 0.05° for microsaccades.

Data analysis
-------------

From the two individual calibrated eye position signals we derived the conjugate signal (left eye + right eye)/2. The onset and the offset of saccades were defined as the time when conjugate eye velocity exceeded or dropped below 10% of the peak velocity. The process was performed automatically by the computer, and the verification was made by visual inspection of the individual eye position and velocity traces. For both gap and overlap tasks latency was measured as the time between target onset (time 0) and saccade onset (mark "i" in Figure [2](#F2){ref-type="fig"}). To estimate the accuracy we used two measures: first, the amplitude of primary main saccade (between "i" and "p") relative to the target eccentricity (gain = saccade amplitude/target eccentricity); second the amplitude of the final eye position (between "i" and "f") after execution of one or more corrective saccades relative to the target eccentricity (see Figure [2](#F2){ref-type="fig"}). Peak velocity of the primary saccade were also analyzed. To evaluate the variability of each parameter, we calculated the coefficient of variation (CV), the relative standard deviation expressed as a unitless proportion of each subjects mean (van Beers, [@B50]; Peltsch et al., [@B34]).

![**Typical recordings of horizontal saccade are obtained by averaging the position signal of the two eyes (LE + RE)/2 and their corresponding velocity traces for one healthy elderly and one DLB patient**. The arrows "i" and "p" indicate the onset and the end of the primary saccade, respectively; the arrow "f" for the final eye position Figure [4](#F4){ref-type="fig"}. Examples of saccade latencies distribution with trials from some controls and DLB patients in the gap task. The mean values and the variability (standard deviation/mean latency) of saccade latency are presented in the box. All three DLB patients show abnormal long latency.](fneur-01-00138-g002){#F2}

Eye movements in the wrong direction, with latency shorter than 80 ms (anticipation) or longer than 1500 ms, or contaminated by blinks were rejected. For healthy elderly 9% of trials (ranged from 4% to 13%) and for patients with DLB 14% of trials (from 2% to 25%) had to be rejected, the most frequent reason being the blinks. Express latencies were defined as those falling in the range from 80 to 120 ms; the rate of express saccades refers to the total number of valid saccades.

Statistical
-----------

A three-way analysis of variance (ANOVA) was performed on individual mean latency with the between subjects factor -- group (healthy, DLB) and the within-subjects factors -- the oculomotor task (gap, overlap) and the direction (left, right, up and down). Two-way ANOVA was performed on individual mean accuracy and velocity means with the between subjects factor (healthy, DLB) and the within-subjects factor (saccade direction). *Post hoc* comparisons were done with the Least Significant Differences test. For the rates of express latency and for the CV of each parameter, the non-parametric Mann--Whitney *U*-test was used for comparisons between healthy elderly and patients with DLB; for within-subjects comparisons between different directions the Friedman and Wilcoxon test was used.

Results
=======

Latency
-------

### Mean Saccade Latency

Figure [3](#F3){ref-type="fig"} shows group mean latencies of saccades with standard error (SE) for different directions under the gap (a) and the overlap (b) tasks in healthy elderly and patients with DLB. The three-way ANOVA showed a group effect, i.e., significantly longer latencies for patients with DLB than for healthy elderly (*F*~1,18~ = 11.83, *p* \< 0.01) and a gap effect, i.e., significantly shorter latencies for gap task than for overlap task (*F*~1,18~ = 47.21, *p* \< 0.01), but no direction effect (*F*~3,51~ = 0.53, *p* = 0.66). Further *post hoc* comparisons showed that the group effect was significant for both gap and overlap tasks for all four directions (all *p* \< 0.05); the mean values of group effect were 164 ms (SD 21 ms) and 176 ms (SD 46 ms) for gap and overlap tasks, respectively. The gap effect was significant for all directions and for both groups of elderly (all *p* \< 0.001). The mean values of gap effect were 105 and 118 ms for healthy elderly and patients with DLB, respectively.

![**Group mean latency of saccades with standard error in gap and overlap tasks, for four directions in healthy elderly and DLB patients; longer latencies of saccades for DLB patients than for healthy elderly for each condition**.](fneur-01-00138-g003){#F3}

### Variability in Saccade Latency

Figure [4](#F4){ref-type="fig"} shows some individual examples of latency variability. Latencies are displayed over successive trials in the gap task. The healthy subjects produce almost similar latency from one trial to next. In contrast, large fluctuations of latency are seen for the DLB subjects.

![**Examples of saccade latencies distribution with trials from some controls and DLB patients in the gap task**. The mean values and the variability (standard deviation/mean latency) of saccade latency are presented in the box. All three DLB patients show abnormal long latency.](fneur-01-00138-g004){#F4}

Figure [5](#F5){ref-type="fig"} shows group mean CV in latency for different direction under the gap (a) and the overlap (b) conditions in healthy elderly and patients with DLB. The Mann--Whitney *U*-test showed the group effect, i.e., significantly high CV in latency for DLB patients than for healthy elderly for all directions (all *U* \< 15, *p* \< 0.01).

![**Group mean coefficient of variation (CV) in saccade latency in gap and overlap tasks, for each direction in healthy elderly and DLB patients**. Variability is higher for DLB patients for all conditions.](fneur-01-00138-g005){#F5}

### Rates of Express Saccades

Table [2](#T2){ref-type="table"} shows individual rate of express latency in the gap task for each direction. In the gap task substantial number of express latency was found. Nine of 10 healthy elderly subjects showed express saccades (rang between 7% and 70%); note the large individual differences. In contrast, only 3 of 10 DLB patients showed express latency. The mean rates for healthy elderly were 20.7%, 19.7%, 11.4%, and 12.1% for leftward, rightward, upward, and downward, respectively; for patients with DLB mean rates were only 3.4%, 2.8% 2.4%, and 0% for each direction, respectively. The Mann--Whitney *U*-test showed the group effect, i.e., significantly lower rates of express latency for patients with DLB than for control elderly (all *U* = \<23, *p* \< 0.05).

###### 

**Rates of express saccades for controls and DLB patients**.

  Subjects       Leftward   Rightward   Upward   Downward
  -------------- ---------- ----------- -------- ----------
  Control 1      0          0           0        0
  Control 2      16         43          7        8
  Control 3      0          0           7        7
  Control 4      25         25          15       8
  Control 5      20         18          12       0
  Control 6      38         25          8        0
  Control 7      25         20          8        43
  Control 8      0          0           11       0
  Control 9      13         16          31       47
  Control 10     70         50          15       8
  Mean control   20.7       19.7        11.4     12.1
  DLB1           0          0           0        0
  DLB2           0          0           0        0
  DLB3           0          0           0        0
  DLB4           0          0           0        0
  DLB5           0          0           0        0
  DLB6           13         8           17       0
  DLB7           15         10          7        0
  DLB8           6          10          0        0
  DLB9           0          0           0        0
  DLB10          0          0           0        0
  Mean DLB       3.4        2.8         2.4      0

Accuracy-speed
--------------

ANOVA applied on the accuracy and speed data showed no significant difference between the gap and the overlap tasks (all *p* \> 0.05). Consequently, accuracy of the primary saccade and of the final eye position, and peak velocity of the primary saccade were regrouped from the two tasks; these grouped results will be presented below.

### Accuracy: Gain of Saccades

Figure [6](#F6){ref-type="fig"} shows group mean gain of the primary saccade and of the final eye position together with SE; results are shown for different directions in healthy elderly and patients with DLB. The two-way ANOVA showed a group effect, i.e., significantly lower gain for patients than for healthy; this was the case for both the primary saccade (*F*~1,18~ = 15.63, *p* \< 0.01) and the final eye position (*F*~1,18~ = 11.28, *p* \< 0.01). Further *post hoc* comparisons showed that the group effect was significant for all directions (all *p* \< 0.001). A direction effect was observed for the final eye position (*F*~3,54~ = 5.08, *p* \< 0.01), i.e., the gain was higher for horizontal saccades (both leftward and rightward) than for vertical saccades (upward or downward, all *p* \< 0.05).

![**Group mean gain of primary saccade and of the final eye position for each direction in healthy elderly and DLB patients; vertical lines are standard error; horizontal lines are gain at 1**. Gain is lower for DLB patients for all directions.](fneur-01-00138-g006){#F6}

### Variability in Gain

Figure [7](#F7){ref-type="fig"} shows the group mean CV for the measured gain from the primary saccade and the final eye position in healthy and in patients. The Mann--Whitney *U*-test showed a group effect, i.e., significantly higher CV in gain for patients than for healthy for all directions and for both accuracy measures (all *U* \< 19, *p* \< 0.05).

![**Group mean coefficient of variation (CV) in the gain of the primary saccade and of the final eye position for each direction in healthy elderly and DLB patients; variability is higher for DLB patients for all directions**.](fneur-01-00138-g007){#F7}

### Velocity

Figure [8](#F8){ref-type="fig"} shows group mean peak velocity of the primary saccade with SE for different directions in healthy and in patients. The two-way ANOVA showed a group effect on peak velocity, i.e., significantly lower peak velocity for patients than for healthy (*F*~1,18~ = 7.45, *p* \< 0.01). Further *post hoc* comparisons showed that the group effect on peak velocity was significant for all directions (all *p* \< 0.001).

![**Group mean value of peak velocity of primary saccade for each direction in healthy and DLB patients; vertical lines are standard error**. Peak velocity is lower for DLB patients for all directions.](fneur-01-00138-g008){#F8}

### Variability in Velocity

Figure [9](#F9){ref-type="fig"} shows group mean CV from peak velocity for each direction in healthy and patients. The Mann--Whitney *U*-test showed a group effect, i.e., significantly higher variability for DLB patients than for healthy (all *U* \< 19, *p* \< 0.05).

![**Group mean coefficient of variation (CV) in peak velocity of the primary saccade for each direction in healthy and DLB patients**. Variability is higher for DLB patients for all directions.](fneur-01-00138-g009){#F9}

As the peak velocity of saccades increases with saccade amplitude increase lower peak velocity for DLB patients could be accounted by lower amplitude of saccades. Therefore, we selected saccades of similar amplitudes (between 9° and 11°), e.g., the most accurate saccades relative to the target eccentricity (10°), and examined peak velocity and variability locally for this subgroup (see Figure [10](#F10){ref-type="fig"}). One-way ANOVA showed no significant difference of mean peak velocity between healthy and patients (*F*~1,18~ = 2.1, *p* = 0.16). Yet, DLB patients showed higher local variability of peak velocity than healthy elderly (*U* = 20, *p* \< 0.05).

![**Group mean peak velocity (with standard error) and its coefficient of variation for saccades of 9° to 11° for healthy and DLB patients; no significant difference of peak velocity between the two groups, yet, coefficient of variation is higher for DLB patients**.](fneur-01-00138-g010){#F10}

Discussion
==========

The main findings are: (1) abnormal long latency of saccades in gap and overlap tasks for DLB relative to healthy elderly occurs for all directions; (2) yet, similar gap effect (shorter latencies in gap than in overlap) exists for healthy and patients; (3) express latencies are absent or minimal in patients, but frequent in healthy; (4) accuracy and peak velocity are lower in DLB patients; (5) variability of all saccade parameters is abnormally high in DLB patients. These results will be discussed below.

Long latencies for dlb for all directions
-----------------------------------------

Our results extend those of horizontal saccades from Mosimann et al. ([@B32]) to vertical saccades showing longer latencies in DLB patients. Abnormally long latencies for all directions reflect dysfunction of common cortical oculomotor areas. The saccade-related activity of the SC neurons is shaped by inputs from the posterior parietal cortex, the frontal eye fields, and the substantia nigra pars reticulata, which control horizontal as well as vertical saccades (Leigh and Zee, [@B28]).

Gap effect
----------

The gap effect refers to the latency advantage of removing the fixation point before the onset of a target (Pratt et al., [@B37]). Such gap effect, shorter latency in the gap task than in the overlap task, was still existent in DLB (118 versus 105 ms in healthy). The percentages of latency decrease in the gap condition, (overlap--gap)/overlap, were similar in healthy elderly (26--42%) and in DLB patients (21--36%). These results are comparable with those reported in young subjects (20--41%, Yang et al., [@B55]). What is the responsible factor for such gap effect is still controversial. The absence of the stimulus during the gap (Findlay and Walker, [@B11]), the offset of fixation (Ross and Ross, [@B43], [@B44]; Reuter-Lorenz et al., [@B40]; Kingstone and Klein, [@B26]; Munoz et al., [@B33]) or advanced movement preparation (Rolfs and Vitu, [@B41]) could explain such phenomena. Although DLB patients showed longer latencies in both gap and overlap tasks than healthy elderly, the disengagement of fixation and perhaps attention was still facilitated by removal of the fixation point in the gap task for these patients.

Quasi paucity of express saccades
---------------------------------

Express latency is usually defined as the latency between 80 and 120 ms. This is, however, arbitrary. Neurophysiological studies (Dorris and Munoz, [@B8]; Edelman and Keller, [@B9]; Sparks et al., [@B48]) have shown that express saccades are produced when visual and motor bursts in the SC merge to produce the saccade. In other words, the visual transient response in the SC caused by the appearance of the target becomes the direct motor command to trigger the saccade. It has been shown that this visual burst of activity in the SC must be added to an elevated baseline to cross the saccade threshold to trigger an express saccade (Dorris and Munoz, [@B8]; Everling et al., [@B10]). Changing the timing of the visual transient response by changing the intensity of the visual stimulus, leads to changes in when express saccades are triggered (Bell et al., [@B3]). Therefore, the express epoch could be specific in each laboratory. In the present study we compare healthy elderly and DLB patients using the same stimuli. Healthy elderly show similar rates of express latency as young adults (Yang and Kapoula, [@B55]; Yang et al., [@B55]). The decreased rates of express latency in DLB patients could suggest a deterioration of the hypothetical express circuit and/or simply a delay in the visual transient response. Yet, the distribution of latencies (over two populations, see Figure [11](#F11){ref-type="fig"}) shows a multiple peak for healthy elderly, namely a peak at 110--120 ms, 160 ms and 190--200 ms while such peak is seen at 150 and 290 ms in DLB patients. In addition to the shift of the peaks, DLB patients showed spread distribution all over the scale. Thus, it is likely that the express circuit, usually attributed to the function of pathways including the parietal saccade regions and the superior colliculus is also impaired in DLB patients (de Bruin et al., [@B7]).

![**Distribution of latencies in the gap condition for healthy elderly (10) and the DLB subjects (10)**.](fneur-01-00138-g011){#F11}

Lower gain and peak velocity
----------------------------

DLB patients showed lower accuracy and peak velocity than control elderly. This is consistent with results in subjects with brainstem lesions. For example, subjects with progressive supranuclear palsy, who have prominent atrophy of the brainstem oculomotor regions (Groschel et al., [@B15]; Boxer et al., [@B5]), displayed deficits in saccade velocity and accuracy. In addition, saccade gain and peak velocity were reduced in adult patients with Niemann--Pick disease, a disorder known to affect brainstem and frontal cortical function (Abel et al., [@B1]). Importantly, in our study the deficits are present for all directions suggesting spread degeneration of both horizontal and vertical saccade generators located in the brainstem. Taken together, when cortical and subcortical neurodegeneration coexists, like in DLB patients, all parameters of reflexive saccades, such as latency, gain, velocity and their variability could be affected.

High variability
----------------

Saccade latency is directly linked to the neural functioning of oculomotor areas, e.g., FEF, PPC (Pierrot-Deseilligny et al., [@B36], [@B35]), SC (Isa and Kobayashi, [@B22]), the substantia nigra pars reticulata and PPRF (Leigh and Zee, [@B28]). Studies of Hanes et al. ([@B16]) showed that a class of movement-related neurons in the FEF have an activity that begins to rise before a saccade. The initiation of the saccade was associated with the activity reaching a fixed threshold and the rate of rise varies randomly from trial to trial. Importantly, the rate of rise was tightly correlated with the observed saccadic latency. A consequence of this observation is that the latency can be modified either by adjustment of the threshold, or by change of the rate of rise. It assumes that a collection of information is made at a certain rate (the rate of rise in the cells) until a threshold criterion is reached: this would cause a decision, in our case, a saccade. Manipulation of perception (Heywood and Churcher, [@B17]), decision criterion level (Reddi and Carpenter, [@B39]), or prior probability (Carpenter and Williams, [@B6]) leads to a change in latency, which could be explained by a change in the threshold. Manipulation of attention also strongly affects the latency, which could be explained by alteration of rate of rise (Heywood and Churcher, [@B17]). Previous studies (Munoz et al., [@B33]; Yang et al., [@B54]) found that variability of latency was significantly larger in children than in adults. This was attributed to poor control over visual fixation. The fixation control system involves a distributed cortical-subcortical circuit, e.g., parietal-frontal-superior colliculus (Fischer et al., [@B12]). Variability on latency depending on cortical structures is consistent with neuropsychological tests, e.g., indicating problems in executive functions and visual attention in DLB patients including working memory (McKeith et al., [@B30]). High variability for saccade metrics could also be related to function of parietal and frontal oculomotor areas providing the position signal error for the brainstem saccade generator (Leigh and Zee, [@B28]). For instance, variation in the representation of the saccade vector in the motor map of the SC could lead to variability in saccade accuracy (Van Opstal and Van Gisbergen, [@B51]). In addition, variability of accuracy can also be related to dysfunction at brainstem saccade generator itself and this is further corroborated by the variability observed on the peak velocity even for the subgroup of the most accurate saccades. Van Beers (van Beers, [@B50]) observed variability of saccades in normal subjects and suggested that at least part of variability of accuracy-speed arises, in the brainstem regions in which the motor commands are generated.

In conclusion, the present study shows many abnormalities in saccades for DLB patients, i.e., increased latency even for tasks expected to promote short latency saccades, absence or reduced rates of express latency, low accuracy and peak velocity, and higher variability for all parameters. Such deficits occur for all four directions. These results reflect dysfunction of both cortical and subcortical oculomotor structures.
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